Smith DW - Search Results

1

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala.

Smith DW, Hewson L, Fuller P, Williams AR, Wheeldon A, Rupniak NM. Smith DW, et al. Brain Res. 1999 Nov 27;848(1-2):90-5. doi: 10.1016/s0006-8993(99)01976-9. Brain Res. 1999. PMID: 10612700

2

Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling.

Guest PC, Knowles MR, Molon-Noblot S, Salim K, Smith D, Murray F, Laroque P, Hunt SP, De Felipe C, Rupniak NM, McAllister G. Guest PC, et al. Brain Res. 2004 Mar 26;1002(1-2):1-10. doi: 10.1016/j.brainres.2003.11.064. Brain Res. 2004. PMID: 14988027

3

Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro.

Maubach KA, Martin K, Smith DW, Hewson L, Frankshun RA, Harrison T, Seabrook GR. Maubach KA, et al. Among authors: smith dw. Neuropharmacology. 2001 May;40(6):806-17. doi: 10.1016/s0028-3908(00)00209-4. Neuropharmacology. 2001. PMID: 11369034

4

Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs.

Boyce S, Smith D, Carlson E, Hewson L, Rigby M, O'Donnell R, Harrison T, Rupniak NM. Boyce S, et al. Neuropharmacology. 2001 Jul;41(1):130-7. doi: 10.1016/s0028-3908(01)00051-x. Neuropharmacology. 2001. PMID: 11445193

5

The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.

Rupniak NM, Webb JK, Fisher A, Smith D, Boyce S. Rupniak NM, et al. Neuropharmacology. 2003 Mar;44(4):516-23. doi: 10.1016/s0028-3908(03)00023-6. Neuropharmacology. 2003. PMID: 12646288

6

Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity.

Conley RK, Cumberbatch MJ, Mason GS, Williamson DJ, Harrison T, Locker K, Swain C, Maubach K, O'Donnell R, Rigby M, Hewson L, Smith D, Rupniak NM. Conley RK, et al. J Neurosci. 2002 Sep 1;22(17):7730-6. doi: 10.1523/JNEUROSCI.22-17-07730.2002. J Neurosci. 2002. PMID: 12196596 Free PMC article.

7

Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM. Kramer MS, et al. Science. 1998 Sep 11;281(5383):1640-5. doi: 10.1126/science.281.5383.1640. Science. 1998. PMID: 9733503 Clinical Trial.

8

CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesion.

Harper SJ, Saporito MS, Hewson L, Young L, Smith D, Rigby M, Jackson P, Curtis N, Swain C, Hefti F, Vaught JL, Sirinathsinghji D. Harper SJ, et al. Neuroreport. 2000 Jul 14;11(10):2271-6. doi: 10.1097/00001756-200007140-00041. Neuroreport. 2000. PMID: 10923684

9

Edg2 receptor distribution in adult rat brain.

Handford EJ, Smith D, Hewson L, McAllister G, Beer MS. Handford EJ, et al. Neuroreport. 2001 Mar 26;12(4):757-60. doi: 10.1097/00001756-200103260-00029. Neuroreport. 2001. PMID: 11277579

10

theta, a novel gamma-aminobutyric acid type A receptor subunit.

Bonnert TP, McKernan RM, Farrar S, le Bourdellès B, Heavens RP, Smith DW, Hewson L, Rigby MR, Sirinathsinghji DJ, Brown N, Wafford KA, Whiting PJ. Bonnert TP, et al. Among authors: smith dw. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9891-6. doi: 10.1073/pnas.96.17.9891. Proc Natl Acad Sci U S A. 1999. PMID: 10449790 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,324 results

Search Page

Filters